US 11382897
Therapeutic combination for treatment of cerebellar ataxia
granted A61KA61K31/197A61K31/423
Quick answer
US patent 11382897 (Therapeutic combination for treatment of cerebellar ataxia) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/197, A61K31/423, A61P, A61P21/00